Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2024-04-25 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
ResMed Announces Results for the Third Quarter of FY2024 10 pages 626.8KB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of financial results for the third quarter of fiscal year 2024 by ResMed Inc. It includes comprehensive financial data such as revenue, gross margin, operating profit, net income, earnings per share, and cash flow figures. It also contains a discussion of the quarter's results, operational highlights, dividend declaration details, and condensed consolidated statements of operations. The presence of extensive financial metrics and analysis for a specific fiscal quarter indicates this is a comprehensive interim financial report rather than a brief earnings release or a simple announcement. The document is about 15,000 characters long, which supports it being a full report rather than a short announcement or webcast notice. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-04-25 English
Dividend/Distribution - RMD 4 pages 15.8KB
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from ResMed Inc regarding a dividend distribution. It specifies the dividend amount, ex-date, record date, and payment date, along with details about the dividend type (ordinary), currency, and withholding tax rate. The document does not contain financial statements or detailed financial analysis but focuses solely on dividend payment information. The length is 4016 characters, which is relatively short and typical for dividend announcements. Therefore, this document fits the category of a Notice of Dividend Amount (DIV).
2024-04-25 English
ResMed to Report Third Quarter Fiscal 2024 Results 1
Regulatory Filings Classification · 95% confidence The document is a short announcement from ResMed about the upcoming release of their third quarter fiscal 2024 earnings on April 25, 2024. It includes details about the webcast for discussing the results and replay information. There are no actual financial results or detailed financial statements included in this text. The document is under 5,000 characters and serves as a notification of an earnings release event rather than the earnings release itself. Therefore, it fits the category of an Earnings Release (ER) announcement rather than the full earnings report or transcript. However, since it is only announcing the upcoming earnings release and webcast, it is best classified as a Regulatory Filing (RNS) because it does not contain the earnings data itself, only the announcement of the event.
2024-04-04 English
Statement of CDIs on issue - RMD 3 pages 12.5KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and contains detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for March 2024, changes in securities, and reasons for changes such as transfers, stock options, employee plans, and share repurchases. The document is a regulatory announcement related to securities issued and changes in capital structure but does not contain financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or management discussion. The document is a formal statement about securities on issue, which aligns with announcements about share issues or capital changes. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is 3044 characters, which is consistent with a detailed announcement rather than a full report.
2024-04-03 English
Statement of CDIs on issue - RMD 3 pages 12.5KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and contains detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities issued by ResMed Inc. It includes monthly statements of securities issued, net differences from previous months, and reasons for changes such as transfers, stock options, employee stock purchase plans, and share repurchases. The document is a regulatory announcement related to securities on issue rather than a financial report, earnings release, or management discussion. It does not contain financial statements or management commentary but is a formal regulatory filing about securities issued and changes in share capital. Given the nature and format, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-03 English
Update - Dividend/Distribution - RMD 4 pages 16.7KB
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding an update to the foreign exchange rate for an upcoming dividend payment by ResMed Inc. It details dividend amounts, payment dates, withholding tax rates, and currency exchange information. There is no financial statement, comprehensive financial data, or management discussion present. The content focuses solely on dividend distribution details and updates to a previous announcement. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related shareholder information.
2024-02-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.